Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization

Transplantation

Volumn 67, Issue 1, 1999, Pages 85-89

  Randhawa, Parmjeet S ^a,b   Saad, Reda S ^a   Jordan, Mark ^a   Scantlebury, Velma ^a   Vivas, Carlos ^a   Shapiro, Ron ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0033556464     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00014     Document Type: Article

References (22)

1. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069.
2. Mihatsch MJ, Ryffel B, Gudat F, Thiel G. Cyclosporine nephropathy. In: Tisher CC, Brenner BM, eds. Renal pathology with clinical and functional correlations. Philadelphia: JB Lippincott, 1989; 1555.
3. Keown PA, Stiller CR, Wallace AC. Nephrotoxicity of cyclosporin A In: Burdick JF, Racusen LC, Solez K, Williams GM, eds. Kidney transplant rejection: diagnosis & Management, 2nd Ed. New York: Marcel Dekker, 1992; 637.
4. Japanese FK 506 Study Group. Morphological characteristics of renal allografts showing renal dysfunction under FK506: is graft biopsy available to reveal the morphological findings corresponding with FK506 nephropathy? Transplant Proc 1993; 25: 624.
5. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients. Am J Surg Pathol 1993; 17: 60.
6. Katari SR, Magnone M, Shapiro R, et al. Clinical features of acute reversible tacrolimus (FK506) nephrotoxicity in kidney transplant recipients. Clin Transplant 1997; 11: 237.
7. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
8. Jain AB, Abu-Elmagd K, Abdallah H, et al. Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol 1993; 33: 606.
9. Jain AB, Pinna A, Fung JJ, et al. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation 1995; 60: 512.
10. Bergstrand A, Bohman SO, Farnsworth A, et al. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clin Nephrol 1985; 24: 107.
11. Versluis DJ, Ten Kate FJ, Wenting GJ, Jeekel J, Weimar W. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants. J Clin Pathol 1988; 41: 498.
12. Farnsworth A, Hall BM, Ng ABP, et al. Renal biopsy morphology in renal transplantation: a comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Am J Surg Pathol 1984; 8: 243.
13. d'Ardenne AJ, Dunnill MS, Thompson JF, McWhinnie D, Wood RFM, Morris PJ. Cyclosporin and renal graft histology. J Clin Pathol 1986; 39: 145.
14. Brunner FP, Hermle M, Mihatsch MJ, Thiel G. Mannitol potentiates cyclosporine nephrotoxicity. Clin Nephrol 1986; 25 (suppl. 1): S130.
15. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol 1997; 17: 15.
16. Solez K, Racusen LC, Marcussen N, Slatnik I, Keown P, Burdick JF, Olsen S. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058.
17. Khader AA, Sulaiman MA, Kishore PN, Morais C, Tariq M. Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats. Transplantation 1996; 62: 427.
18. Andoh TF, Burdmann EA, Lindsley J, Houghton DC, Bennett WM. Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. Transplantation 1994; 57: 483.
19. Bullock WE, Luke RG, Nuttall CE, Bhathena D. Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrob Agents Chemother 1976; 10: 555.
20. O'Keefe DA, Sisson DD, Gelberg HB, Schaeffer DJ, Krawiec DR. Systemic toxicity associated with doxorubicin administration in cats. J Vet Intern Med 1993; 7: 309.
21. Pirolo JS, Hutchins GM, Moore GW. Myocyte vacuolization in infarct border zones is reversible. Am J Pathol 1985; 121: 444.
22. Tashiro A, Satodate R, Segawa I. Histological changes in cardiac hemochromatosis improved by an iron-chelating agent: a biopsy case. Acta Pathol Jpn 1990; 40: 288.